Results 321 to 330 of about 1,671,076 (389)

Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.

American Journal of Psychiatry, 2014
A. Loebel, J. Cucchiaro, Robert Silva, H. Kroger, K. Sarma, Jane Xu, J. Calabrese   +6 more
semanticscholar   +1 more source

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

Ca-A Cancer Journal for Clinicians, 2022
William A Hal, X Allen Li, Daniel A Low
exaly  

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

American Journal of Psychiatry, 2000
S. Kapur, R. Zipursky, Corey Jones, G. Remington, S. Houle, C. F.R.C.P.   +5 more
semanticscholar   +1 more source

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.

The Lancet, 2001
T. Smilde, S. V. van Wissen, H. Awollersheim, M. Trip, J. Kastelein, A. Stalenhoef   +5 more
semanticscholar   +1 more source

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.

The Lancet, 2011
E. Krupitsky, E. Nunes, W. Ling, A. Illeperuma, D. Gastfriend, B. Silverman   +5 more
semanticscholar   +1 more source

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.

The Lancet, 2009
J. Mega, E. Braunwald, Satishkumar Mohanavelu, P. Burton, R. Poulter, F. Misselwitz, V. Hricák, E. Barnathan, P. Bordes, A. Witkowski, V. Markov, L. Oppenheimer, C. Gibson   +12 more
semanticscholar   +1 more source

Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.

American Journal of Psychiatry, 2011
H. Meltzer, J. Cucchiaro, Robert Silva, M. Ogasa, D. Phillips, Jane Xu, A. Kalali, E. Schweizer, A. Pikalov, A. Loebel   +9 more
semanticscholar   +1 more source

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.

American Journal of Psychiatry, 2005
J. Calabrese, P. Keck, W. Macfadden, M. Minkwitz, T. Ketter, R. Weisler, A. Cutler, R. McCoy, E. Wilson, J. Mullen   +9 more
semanticscholar   +1 more source

A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression.

Journal of Clinical Psychiatry, 2011
A. Wirz-Justice, Anja Bader, U. Frisch, R. Stieglitz, J. Alder, J. Bitzer, I. Hösli, Sandra Jazbec, F. Benedetti, M. Terman, K. Wisner, A. Riecher-Rössler   +11 more
semanticscholar   +1 more source

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.

Journal of Clinical Psychiatry, 2010
Y. Levkovitz, Shlomo Mendlovich, S. Riwkes, Y. Braw, H. Levkovitch-Verbin, G. Gal, S. Fennig, I. Treves, S. Kron   +8 more
semanticscholar   +1 more source